Ajmaline

Jump to: navigation, search
Ajmaline
Ajmaline svg.png
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H26N2O2
Molar mass326.433 g/mol

WikiDoc Resources for Ajmaline

Articles

Most recent articles on Ajmaline

Most cited articles on Ajmaline

Review articles on Ajmaline

Articles on Ajmaline in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ajmaline

Images of Ajmaline

Photos of Ajmaline

Podcasts & MP3s on Ajmaline

Videos on Ajmaline

Evidence Based Medicine

Cochrane Collaboration on Ajmaline

Bandolier on Ajmaline

TRIP on Ajmaline

Clinical Trials

Ongoing Trials on Ajmaline at Clinical Trials.gov

Trial results on Ajmaline

Clinical Trials on Ajmaline at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ajmaline

NICE Guidance on Ajmaline

NHS PRODIGY Guidance

FDA on Ajmaline

CDC on Ajmaline

Books

Books on Ajmaline

News

Ajmaline in the news

Be alerted to news on Ajmaline

News trends on Ajmaline

Commentary

Blogs on Ajmaline

Definitions

Definitions of Ajmaline

Patient Resources / Community

Patient resources on Ajmaline

Discussion groups on Ajmaline

Patient Handouts on Ajmaline

Directions to Hospitals Treating Ajmaline

Risk calculators and risk factors for Ajmaline

Healthcare Provider Resources

Symptoms of Ajmaline

Causes & Risk Factors for Ajmaline

Diagnostic studies for Ajmaline

Treatment of Ajmaline

Continuing Medical Education (CME)

CME Programs on Ajmaline

International

Ajmaline en Espanol

Ajmaline en Francais

Business

Ajmaline in the Marketplace

Patents on Ajmaline

Experimental / Informatics

List of terms related to Ajmaline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ajmaline is a class Ia antiarrhythmic agent. It is often used to bring out typical findings of ST elevations in patients suspected of having Brugada syndrome.

The compound was first isolated by Salimuzzaman Siddiqui in 1931 [1] from the roots of Rauwolfia serpentina. He named it Ajmaline, after Hakim Ajmal Khan, one of the most illustrious practitioners of Unani system of medicine in South Asia.[2]

References

  1. Siddiqui, S. & Siddiqui, R.H. (1931). Journal of the Indian Chemical Society, vol. 8, pp. 667-680.
  2. Ahmed Nasim Sandilvi (2003), Salimuzzaman Siddiqui: pioneer of scientific research in Pakistan. Daily Dawn. 12 April, 2003. Retrieved on 19 July, 2007.

Linked-in.jpg